bpc-157 evidence human clinical trials safety regulatory status Peptide: Benefits for Healing, Recovery & Nerve Repair bpc-157 human clinical trials evidence

showed that in the emergency department, the circulating concentration of syndecan-1, a marker of glycocalyx degradation, correlates with the fluid requirement, severity of sepsis, extent of organ dysfunction, and risk of mortality, but a direct relationship with glycocalyx degradation has not been identified (123)

Limitations Our study lacked a large sample size, ethnic variation, and sham control group

Pappalardo, F., Rajput, A

While B-mode images revealed qualitative changes in echogenicity and apparent changes in size among groups, such measures are susceptible to being confounded by differences in system or user

There is no preservative to suppress microbial growth